CL
CellaVision AB (publ)
CLVSF · OTC
$14.00 +0.00% (+$0.00)
Market Cap 3.28B kr
P/E Ratio 25.50x
Div. Yield 2.12%
ROE 14.59%
Bulios Fair Price
$10.1
27.9% downside
Trenutna cena
$14
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CLVSF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
43 /100
Fair P/E 25.50x
EV/EBITDA 16.82x
PEG 2.44x
Growth
66 /100
Stable EPS growth 8.98%
Rev. growth 5.88%
Book val. growth 11.42%
Profitability
93 /100
Strong Gross margin 68.71%
Net margin 17.47%
FCF margin 15.33%
Quality
71 /100
Excellent ROIC 12.74%
ROE 14.59%
Asset turnover 0.65x
Debt
100 /100
Low Debt/Equity 0.06x
Current ratio 3.31x
Net debt/EBITDA -0.63x
Stability
100 /100
Stable Beta 0.87x
Rev. volatility 0.92%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CLVSF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Steve Ferguson
Employees
251
Headquarters
Lund
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report